Rare diseases
Investigational molecules
Locations
9715 Key West Avenue, 20850-3900, United States
Clinical research activity is centered on epilepsy, with a specific focus on focal onset seizures in adults. The sponsor’s trial portfolio reflects interest in seizure control and the treatment of neurologic disorders that affect daily functioning and safety.
Research efforts are directed toward therapeutic options for adults living with recurrent seizure activity and related neurologic symptoms.
Supernus Pharmaceuticals Inc. runs clinical trials in conditions such as Partial seizures, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
